
Quigly Dragotakes
Articles
-
May 21, 2024 |
biorxiv.org | Isabel Jiménez |Quigly Dragotakes |Piotr R. Stempinski |Seth D. Greengo
AbstractCryptococcus is a genus of saprophytic fungi with global distribution. Two species complexes, C. neoformans and C. gattii, pose health risks to humans and animals. Cryptococcal infections result from inhalation of aerosolized spores and/or desiccated yeasts from terrestrial reservoirs such as soil, trees, and avian guano. More recently, C.
-
May 18, 2024 |
medrxiv.org | Quigly Dragotakes |David Sullivan |Rickey E. Carter |Michael Joyner
The authors have declared no competing interest. This study did not receive any fundingI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
-
Apr 6, 2024 |
biorxiv.org | Quigly Dragotakes |Arturo Casadevall |Johns Hopkins
AbstractCryptococcus neoformans is a fungal pathogen that causes cryptococcosis mostly in immune compromised patients, such as those with HIV/AIDS. One survival mechanism of C. neoformans during infection is melanin production, which catalyzed by laccase, and protects fungal cells against immune attack. Hence comparative assessment of laccase activity is useful for characterizing cryptococcal strains. We serendipitously observed that culturing C.
-
Jan 1, 2024 |
biorxiv.org | Quigly Dragotakes |Arturo Casadevall |Johns Hopkins
AbstractCryptococcus neoformans is a fungal pathogen that causes cryptococcosis mostly in immune compromised patients, such as those with HIV/AIDS. One survival mechanism of C. neoformans during infection is melanin production, which is catalyzed by laccase. Hence comparative assessment of laccase activity is useful for characterizing cryptococcal strains. After a serendipitous observation that culturing C.
-
Jun 14, 2023 |
biorxiv.org | Quigly Dragotakes |Arturo Casadevall |Johns Hopkins
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →